Seeking Alpha

BVTI.PK
Biovest International Inc.

5/27/2012, 7:30 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
BVTI.PK Market Currents more »
Currently, there are no Market Currents on BVTI.PK.
BVTI.PK in Focus more »
BVTI.PK News more »
Currently, there are no news on BVTI.PK.
BVTI.PK Press Releases and Filings more »
Currently, there are no press releases or filings on BVTI.PK.
BVTI.PK Latest Transcript more »
Currently, there are no transcripts for BVTI.PK.
BVTI.PK Cramer more »
Currently, there are no Cramer articles on BVTI.PK.
BVTI.PK Instablog posts more »
  • RXI's Orphan Drug & Fast Track Index (27 Stocks) => Rx Investors.com
    Tue, Nov 9, 2010 • Justin M. Hall • 1 Comment
  • Who has the next approvable cancer vaccine?
    Sun, May 16, 2010 • James Hill, MD • 8 Comments
  • Biovest files bankruptcy reorganization plan that preserves shares
    Sun, May 16, 2010 • James Hill, MD • 1 Comment
  • Kennedy Brain Cancer Solutions Delayed by Health Care Bill
    Mon, Jan 18, 2010 • Solver • 1 Comment
  • Biovest Inches Closer to Cancer Vaccine NDA Filing (OTC:BVTI)
    Tue, Sep 22, 2009 • Michael Catalin Vlaicu • Comment!
Write a post on BVTI.PK
BVTI.PK StockTalks
BVTI.PK vs. ETF Alternatives
Company Description

We are a biotechnology company focusing primarily on the development of BiovaxID™, a patient-specific anti-cancer vaccine focusing on the treatment of follicular non-Hodgkins lymphoma, or follicular NHL. Follicular NHL is a cancer of the lymphatic system that results when the body’s follicle... More

Sector: Technology
Industry: Biotechnology
Country: United States